IndraLab

Statements


| 7 3

sparser
"Accordingly, mutations in VCP/p97 that cause IBMPFD (R155H and A232E) disrupt both the physical and functional interaction with CHMP5 and USP15."

reach
"Collectively, these data suggest that the CHMP5 and USP15 complex suppresses RANK mediated NF-kappaB activation via IkappaBalpha stabilization in osteoclasts, in which mechanism it prevents proteasomal degradation of IkappaBalpha leading to the retention of NF-kappaB in an inactive cytosolic complex."

reach
"To confirm the observation that the CHMP5 complex in osteoclasts contains the deubiquitinating enzyme USP15 and VCP and p97 (XREF_FIG), the physical interactions between CHMP5, USP15, and VCP and p97 were studied using cell-free immunoprecipitation analysis (XREF_FIG)."

reach
"Furthermore, immunoprecipitation analysis confirmed that both endogenous and overexpressed CHMP5 interact with USP15, VCP and p97, and beta-Trcp in an osteoclast line and HEK293 cells, respectively (XREF_FIG and unpublished data)."

reach
"Intriguingly, CHMP5 interacts directly with both USP15 and VCP and p97, whereas there was no direct interaction between USP15 and VCP and p97."

sparser
"To confirm the observation that the CHMP5 complex in osteoclasts contains the deubiquitinating enzyme USP15 and VCP/p97 ( xref ), the physical interactions between CHMP5, USP15, and VCP/p97 were studied using cell-free immunoprecipitation analysis ( xref )."

sparser
"Intriguingly, CHMP5 interacts directly with both USP15 and VCP/p97, whereas there was no direct interaction between USP15 and VCP/p97."

reach
"This also raises the possibility that VCP and p97 serves an important function to select the substrates targeted by the CHMP5 and USP15 complex for deubiquitination."

reach
"Therefore, we speculated whether CHMP5 regulates OA progression by binding to USP15 and NF-κB signaling pathway."

reach
"As expected, our current investigation showed that CHMP5 was capable of binding USP15 to inhibit IκBα ubiquitination, thereby suppressing enhanced apoptosis and ECM degradation induced by IL-1β through NF-κB signaling pathway in OA chondrocytes.Taken together, CHMP5 alleviates OA development by decreasing OA chondrocyte apoptosis and ECM degradation caused by IL-1β via NF-κB signaling pathway (Fig. 8)."